InventisBio Co., Limited (SHA:688382)
China · Delayed Price · Currency is CNY 25.87
-1.66 (-6.03%)
At close: Jan 22, 2026
InventisBio Market Cap
InventisBio has a market cap or net worth of 15.92 billion as of January 22, 2026. Its market cap has increased by 141.32% in one year.
Market Cap
15.92B
Enterprise Value
14.41B
Revenue
180.53M
Ranking
n/a
PE Ratio
n/a
Stock Price
25.87
Market Cap Chart
Since July 25, 2022, InventisBio's market cap has increased from 8.79B to 15.92B, an increase of 81.10%. That is a compound annual growth rate of 18.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 14.96B | -5.03% |
| Dec 31, 2025 | 15.75B | 105.38% |
| Dec 31, 2024 | 7.67B | -11.89% |
| Dec 29, 2023 | 8.71B | 14.01% |
| Dec 30, 2022 | 7.64B | -13.15% |
| Jul 25, 2022 | 8.79B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sinocelltech Group | 20.25B |
| Inner Mongolia Furui Medical Science | 19.58B |
| Jinyu Bio-technology | 19.23B |
| Anhui Anke Biotechnology (Group) | 17.04B |
| Mabwell (Shanghai) Bioscience | 15.74B |
| Tibet Cheezheng Tibetan Medicine | 13.84B |
| Pacific Shuanglin Bio-pharmacy | 13.36B |
| Beijing Hotgen Biotech | 13.24B |